ReviewMolecular medicine (Cambridge, Mass.)2024

Targeting microbial pathogenic mechanisms as a novel therapeutic strategy in IBD.

Paul F MillerPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.